O
Outpace Bio
Biotech & Life Sciences · Seattle, United States · Founded 2020
Revolutionizing cell therapy with protein design, Outpace reprograms immune cells to make better decisions inside patients, enhancing cell therapy persistence and overcoming biology barriers to cancer… MoreLess
Outpace Bio is a biotech startup that is revolutionizing cell therapy through innovative protein design. The company aims to cure solid tumors by creating new proteins that can guide cells to recognize and eliminate cancer in the body. The company's founders have pioneered a new era in protein design, shifting from designing structures to creating new biological functions.
Outpace Bio's business model revolves around solving three key problems in curing solid tumors: the tumor's suppression of our immune response, the limited persistence of cell therapy, and the limited potency, safety, and specificity of cell therapy. To address these issues, the company has developed technologies that stimulate productive immune responses, enable potent and persistent cell therapy activity, and maximize the potency, safety, and specificity of cell therapies across diverse cancer indications.
The company uses AI-powered protein design to create proteins that program engineered cells for improved function inside patients. These proteins are then combined to develop cell therapy products with curative potential. Outpace Bio's platform technologies can power any cell type and manufacturing approach, making it a versatile player in the biotech industry.
The company operates in the biotech market, serving clients in the medical and healthcare sectors. It generates revenue by developing and selling its innovative cell therapy products and technologies.
Keywords: Biotech, Cell Therapy, Protein Design, Cancer Treatment, AI-Powered, Solid Tumors, Immune Response, Potency, Safety, Specificity.
Company overview
Outpace Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Seattle, United States
- Employees
- 73
- Open positions
- 1
- Dealroom signal
- 76.7
Valuation & funding
Outpace Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2024 | $144M | $576M | Qatar Investment Authority · Artis Ventures · Breton Capital Management · Abstract Ventures | ↗ |
| SERIES AOther financing | Mar 2023 | $25M | $100M | Bristol-Myers Squibb · Playground Global · Civilization Ventures · Sahsen Ventures | ↗ |
| SERIES AOther financing | Mar 2021 | $30M | $120M | Abstract Ventures · Civilization Ventures · Sahsen Ventures · Mubadala Capital | — |
| SPINOUTOther financing | Nov 2020 | — | — | University of Washington Institute for Protein Design | — |
Growth signals
Outpace Bio website traffic
Latest recorded traffic for Outpace Bio is 3.7K monthly website visits, down 17.8% over the last three months. Outpace Bio's team grew 7.4% over the past year.
Comparisons
Outpace Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Outpace Bio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Outpace Bio has talent and traffic
team presence
In the news
Latest news about Outpace Bio
Recent press, funding announcements, and product moves mentioning Outpace Bio — open to read from the original sources.
Market sentiment
What the market is saying about Outpace Bio
An AI-synthesized read of the highest-engagement posts about Outpace Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Outpace Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.